Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome; a Randomized Control Trial
Phase of Trial: Phase II/III
Latest Information Update: 30 Oct 2017
Price : $35 *
At a glance
- Drugs Levacecarnine (Primary)
- Indications Carpal tunnel syndrome
- Focus Therapeutic Use
- 25 Oct 2017 Status changed from recruiting to completed.
- 31 Mar 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2017 as reported by ClinicalTrials.gov.
- 31 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 May 2017 as reported by ClinicalTrials.gov.